To be a leading center of excellence in research and innovation for fungal infection diagnosis and therapy, powered by cutting-edge science and technology, while contributing significantly to the advancement of knowledge, the enhancement of healthcare quality, and the achievement of the Sustainable Development Goals (SDGs), particularly Good Health and Well-Being (SDG 3).
To advance basic, translational, and clinical research in medical mycology to foster innovation in diagnostic methods and fungal infection therapies.
To develop and implement rapid, sensitive, and specific diagnostic technologies based on the latest molecular advancements and biomarkers.
To develop innovative antifungal therapeutic strategies, including the exploration of novel agents, combination therapies, and approaches centered on resistance and precision medicine.
To produce reputable scientific publications, patents, and innovative products that deliver a tangible impact on healthcare services.
To establish multidisciplinary research collaboration networks at both national and international levels to strengthen innovation capacity and the downstream application of research findings.
To integrate research outcomes into clinical practice and health policy to enhance the effectiveness of fungal infection prevention and management.